Live Breaking News & Updates on Eagle Pharmaceuticals
Stay updated with breaking news from Eagle pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts at StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Price Performance Eagle Pharmaceuticals stock opened at $3.81 on Tuesday. Eagle Pharmaceuticals has a one year low of […] ....
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Investigation Alert Baxter International, Eagle globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.47 and traded as low as $4.57. Eagle Pharmaceuticals shares last traded at $4.69, with a volume of 161,336 shares changing hands. Eagle Pharmaceuticals Stock Up 2.1 […] ....
DGS Capital Management LLC purchased a new position in shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,419 shares of the specialty pharmaceutical company’s stock, valued at approximately $60,000. DGS Capital […] ....